Navigation Links
Raging Capital Sends Letter to Taro Pharmaceutical Board of Directors in Opposition to Inadequate Acquisition Offer by Sun Pharmaceutical
Date:11/3/2011

60;In this instance, however, as of October 31, 2011 the price of Sun Pharma's common stock was actually up more than 9% since the announcement of the Acquisition Proposal, demonstrating that the market believes Sun Pharma is getting Taro at below value.

Sound corporate governance and well-established principles of fairness and equity in both Israel and the U.S. mandate that the Board set up a mechanism for the evaluation of the Acquisition Proposal that would frustrate any coercive attempts by Sun Pharma to take advantage of Taro's minority shareholders.  We expect Taro to follow through with its stated intention of forming a special committee to review the Acquisition Proposal.  It is imperative that such a special committee is composed of members who are truly independent from Sun Pharma.  The need for such a disinterested special committee is heightened by the fact that many of the members of the current Board were appointed by Sun Pharma in September 2010 in connection with the transaction through which Sun Pharma gained a controlling stake in the Company, including the letter agreement and settlement agreement between Sun Pharma and the families of the Company's founders.  Furthermore, such a disinterested special committee should have a stated purpose to fully protect the minority shareholders of Taro and a clear mandate to evaluate and take all appropriate and available steps to ensure that the rights of Taro's minority shareholders are not trampled on.  

Equally as important as the composition of any special committee that is formed is the scope of its authority. In this regard, we believe it is critical that the special committee have the authority to explore all potential transactions, and not be limited to simply negotiating the terms of a transaction with Sun Pharma. We think it important that the Special Committee be specifically authorized to contact other potential strategic and financial bidders prior to
'/>"/>

SOURCE Raging Capital Management, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Delcath Announces Encouraging Top-Line Results From Hepatobiliary Cohort in Phase II Trial of Chemosaturation System
2. SAR 1118 Demonstrates Encouraging Results in Phase 2 Study of Dry Eye Disease
3. comScore Announces Availability of Media Planning Tool Leveraging Behavioral Insights into Online Usage Habits of Doctors
4. Power Wheelchair From Medicare Helps Save Elderly Alabama Woman From Raging Fire That Destroyed Her Home of 40 Years
5. Stimatix GI Reports Encouraging Interim Results
6. Mississippians React to Rushed Pseudoephedrine Debate Raging in the State Legislature
7. Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution
8. Patients who Participated in Pleio GoodStart(TM) Refilled 30% Sooner and 40% More, Averaging 2 Additional Rx Refills per Patient
9. AFFiRiS AG - Encouraging Results From Phase I Studies of two Alzheimers Candidate Vaccines Trigger a EUR 10 Million Milestone Payment
10. NKTR-102 Shows Encouraging Anti-Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplinary Congress
11. Encouraging First Data on New Targeted Treatment for Patients With Melanoma - the Deadliest Form of Skin Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Wash. , Dec. 19, 2014  Advanced ... stage development company engaged primarily in the development ... and therapeutic applications, today announced that a Life ... has been awarded for which AMIC is the ... State University (WSU) for the proposal titled "Optimized ...
(Date:12/19/2014)... 2014 In today,s rapidly changing, highly ... tools are essential for survival. The world is ... desires, preferences, and unmet needs are evolving rapidly. ... across all industries are continually searching for innovative ... adoption of new market research techniques like mobile ...
(Date:12/19/2014)... , Dec. 18, 2014 Somewhere between ... hearing health was forgotten. But Audicus , a ... hear better this new year. Hearing loss ... the aging population, though it is often unaddressed. Forty-eight ... four has a hearing aid, mainly due to price. ...
Breaking Medicine Technology:Advanced Medical Isotope Corporation Awarded LSDF Grant As Commercialization Partner 2Advanced Medical Isotope Corporation Awarded LSDF Grant As Commercialization Partner 3Study Uncovers New Tools and Techniques for Understanding Consumer Decision Making 2Audicus Will Help People Resolve to Hear Better in 2015 2
... 20 Valor Medical, an emerging medical,device company in ... of Neucrylate AN for treatment of cerebral aneurysms was ... The treatment was under the,guidance of a clinical protocol ... Dr. Pakbaz stated that the patient,s aneurysm was ...
... Ages, ALEXANDRIA, Va., March 19 A ... 18, 2008) reports that pelvic,floor muscle training, in ... incontinence in women. According to the American,Physical Therapy ... physical therapist can help patients manage, if not,alleviate, ...
Cached Medicine Technology:New Study Reports That Physical Therapy Treatment Resolves Symptoms of Urinary Incontinence in Women 2New Study Reports That Physical Therapy Treatment Resolves Symptoms of Urinary Incontinence in Women 3New Study Reports That Physical Therapy Treatment Resolves Symptoms of Urinary Incontinence in Women 4
(Date:12/20/2014)... San Francisco, CA (PRWEB) December 20, 2014 ... a Social Innovation company just launched first birthday focused ... the services, “MERRY BIRTHDAY MESSAGE” launched in both US ... , MERRY BIRTHDAY MESSAGE : http://merrybirthday.net/message/ , ... launching for everyone’s birthday around the world. , Features, ...
(Date:12/20/2014)... (PRWEB) December 20, 2014 Developers of ... release of a new plugin for Final Cut Pro ... , “TranSlice Volume 5 allows users to create hand ... it.” Said Christina Austin, CEO of Pixel Film Studios. ... of professionalism while maintaining an easy to use interface.” ...
(Date:12/20/2014)... Parker & Sons, Inc. a focused and ... in contractor services announces reaching a milestone by providing ... of Arizona. Parker and Sons is comprised of a ... make customer service the number one priority. The company ... with one service vehicle and has since grown to ...
(Date:12/19/2014)... 20, 2014 It’s very easy to become ... that is put to the wayside until Christmas and the ... that travel “itch” and that burning desire to just escape ... on their journey to Telluride with a no-fuss, affordable package. ... and from the resort, and ensure that all accommodations are ...
(Date:12/19/2014)... FL (PRWEB) December 19, 2014 ... Revitalizing Bedsheets are now available. Celliant, the world’s ... both sheets and pillowcases. , There are a ... proven additional circulation, increased oxygenation and balanced body ... faster healing and pain relief; enhanced athletic performance; ...
Breaking Medicine News(10 mins):Health News:Atore, Inc. Releasing the First Birthday Portal 2Health News:Pixel Film Studios released a new transition entitled TranSlice Volume 5 exclusively for Final Cut Pro X 2Health News:Parker & Sons Announces Reaching A Milestone By Providing 40 Years Of Dedicated Contractor Services For Homeowners Of Arizona 2Health News:Parker & Sons Announces Reaching A Milestone By Providing 40 Years Of Dedicated Contractor Services For Homeowners Of Arizona 3Health News:Days Inn Montrose Colorado Delivers Last Minute Holiday Season Ski Getaway Accommodations 2Health News:Energy Textiles Launches Celliant Revitalizing Bedsheets 2
... Aero Financial, Inc, a strategic advisory and finance & ... been retained as a strategic consulting partner by Only ... information and nutrition products.Pursuant to the consulting agreement, Aero ... of the company,s growth plans, including:, ...
... Industry Professionals Available for Comment on Health Reform under Obama ... ... LLP today published a brief entitled 10 Minutes on Health ... alter the employer-based insurance system, the advantages of universal healthcare ...
... Why? , ... (PRWEB) January 22, 2009 -- Web 2.0, Health 2.0, ... are appearing more and more in the healthcare space and many hospital ... their marketing plans as another way to increase market share and build ...
... SEATTLE, Jan. 22 Cell Therapeutics, Inc. (CTI),(Nasdaq and ... by,Esmaeli, et al. online on January 15, 2009 in ... agent Zevalin (ibritumomab,tiuxetan) in a front-line setting for patients ... involved the conjunctiva or orbit,produced a complete response rate ...
... HealthSystem,Consortium (UHC) today announced that after a competitive ... measurement services to Avatar,International and Press Ganey Associates, ... with options to extend. The agreements are effective ... Under the agreements, Avatar and Press Ganey ...
... Gen. Eric K. Shinseki took the oath of office ... assuming the leadership of the Department of Veterans Affairs ... am addressing from my first day in office is ... century organization focused on the Nation,s Veterans as its ...
Cached Medicine News:Health News:Aero Financial Retained as Strategic Consultant by Only Natures Finest(TM) 2Health News:Media Alert: PricewaterhouseCoopers Publishes Brief on the Impact of Government Health Reform on U.S. Employers 2Health News:Media Alert: PricewaterhouseCoopers Publishes Brief on the Impact of Government Health Reform on U.S. Employers 3Health News:Media Alert: PricewaterhouseCoopers Publishes Brief on the Impact of Government Health Reform on U.S. Employers 4Health News:Hope is Not a Strategy: Neither is Web 2.0 for a Hospital 2Health News:Hope is Not a Strategy: Neither is Web 2.0 for a Hospital 3Health News:Treatment with the Zevalin(R) Therapeutic Regimen as Sole Therapy Produces 83 Percent Complete Response Rate in Mucosa-Associated Lymphoid Tissue (MALT) Orbital Lymphoma 2Health News:Treatment with the Zevalin(R) Therapeutic Regimen as Sole Therapy Produces 83 Percent Complete Response Rate in Mucosa-Associated Lymphoid Tissue (MALT) Orbital Lymphoma 3Health News:Treatment with the Zevalin(R) Therapeutic Regimen as Sole Therapy Produces 83 Percent Complete Response Rate in Mucosa-Associated Lymphoid Tissue (MALT) Orbital Lymphoma 4Health News:University HealthSystem Consortium Announces Dual Award for Patient Satisfaction Measurement Services 2Health News:Shinseki Sworn In, Vows 21st Century Service to Veterans 2
4 mm blade. Flat handle....
9 mm button end blade. 15 mm long backcutting blade. Angled at 45 degrees. Flat handle. Designated most popular model or size....
10 mm blade, angled left. Flat handle....
4 mm blade. Bayonet. Flat handle....
Medicine Products: